We are pleased to announce that the Journal of Gastrointestinal Oncology (JGO) has attained its latest impact factor update for the 2023 citation year: 2 (Figure 1).
Figure 1. New impact factor and related metrics of JGO
Journal of Gastrointestinal Oncology (Print ISSN 2078-6891; Online ISSN 2219-679X; J Gastrointest Oncol; JGO), the official journal of Society for Gastrointestinal Oncology (SGO), is an open-access, international peer-reviewed journal. JGO publishes manuscripts that focus on updated and practical information about diagnosis, prevention and clinical investigations of gastrointestinal cancer treatment. Specific areas of interest include, but not limited to, multimodality therapy, markers, imaging and tumor biology. JGO has been indexed by PubMed, PubMed Central (PMC), Scopus, Science Citation Index Expanded (SCIE).
We will strive to follow the best practices in publishing. Our impact factor is an important validation that demonstrates the increased recognition of JGO in the field, and the improved relevance and quality of our articles. Here, we would like to extend our heartfelt gratitude to all our Editorial Team Members, Guest Editors, authors, and reviewers for their valuable contributions.
We look forward to the continuous cooperation with all the individuals mentioned above and those who are interested in gastrointestinal oncology to bring more exciting content to readers in the coming future.
Editorial Office
Journal of Gastrointestinal Oncology
June 20, 2024